| Reaction Details |
|---|
 | Report a problem with these data |
| Target | D(1B) dopamine receptor |
|---|
| Ligand | BDBM50130293 |
|---|
| Substrate/Competitor | n/a |
|---|
| Ki | 2590±n/a nM |
|---|
| Comments | PDSP_3130 |
|---|
| Citation |  Shapiro, DA; Renock, S; Arrington, E; Chiodo, LA; Liu, LX; Sibley, DR; Roth, BL; Mailman, R Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology28:1400-11 (2003) [PubMed] Article |
|---|
| More Info.: | Get all data from this article |
|---|
| |
| D(1B) dopamine receptor |
|---|
| Name: | D(1B) dopamine receptor |
|---|
| Synonyms: | D(5) dopamine receptor | D1beta dopamine receptor | DOPAMINE D5 | DRD1B | DRD1L2 | DRD5 | DRD5_HUMAN | dopamine receptor D5 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 52943.41 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P21918 |
|---|
| Residue: | 477 |
|---|
| Sequence: | MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLLIIWTLLGNVL
VCAAIVRSRHLRANMTNVFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAFCDVWVAFD
IMCSTASILNLCVISVDRYWAISRPFRYKRKMTQRMALVMVGLAWTLSILISFIPVQLNW
HRDQAASWGGLDLPNNLANWTPWEEDFWEPDVNAENCDSSLNRTYAISSSLISFYIPVAI
MIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSSAACAPDTSLRASIKKETKVLKTLSV
IMGVFVCCWLPFFILNCMVPFCSGHPEGPPAGFPCVSETTFDVFVWFGWANSSLNPVIYA
FNADFQKVFAQLLGCSHFCSRTPVETVNISNELISYNQDIVFHKEIAAAYIHMMPNAVTP
GNREVDNDEEEGPFDRMFQIYQTSPDGDPVAESVWELDCEGEISLDKITPFTPNGFH
|
|
|
|---|
| BDBM50130293 |
|---|
| n/a |
|---|
| Name | BDBM50130293 |
|---|
| Synonyms: | 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one | ARIPIPRAZOLE | CHEMBL1112 | US10174011, aripiprazole | US10752588, Compound Aripiprazole | US11498896, Compound Aripiprazole | US9018213, aripprazole | US9156822, Aripiprazole |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C23H27Cl2N3O2 |
|---|
| Mol. Mass. | 448.385 |
|---|
| SMILES | Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl |
|---|
| Structure | 
|
|---|
Search and Browse
